Tuesday, August 10, 2021 11:51:20 AM
https://finance.yahoo.com/news/instil-bio-reports-first-quarter-110000823.html?.tsrc=rss
Thursday, Aug 12 will be SECOND QUARTER RESULTS:
??
And the stunning truth of the matter is that this generation, save the military, doesn’t value freedom. Instead, it values comfort. It values convenience and coddling, and conformity.
Recent TIL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 05:07:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 10:02:25 AM
- Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer • GlobeNewswire Inc. • 09/16/2024 10:00:00 AM
- Dell, Palantir, and Erie Will Be Added to the S&P 500; Boeing Avoids Strike; Apple Event Takes Place Today • IH Market News • 09/09/2024 10:05:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:02:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 09:16:42 PM
- Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/13/2024 09:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 09:00:16 PM
- Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody • GlobeNewswire Inc. • 08/01/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 09:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 09:02:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:03:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:02:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 11:10:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 11:01:17 AM
- Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/10/2024 11:00:00 AM
- Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 09:00:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:08:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:36:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 12:01:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:00:34 PM
- Instil Bio Announces Strategic Update • GlobeNewswire Inc. • 01/16/2024 01:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 01:10:49 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM